Target intelligence / Profile preview

Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (GATB)

Target
GATB
Molecular classification
Enzyme, Aminotransferase/Amidotransferase complex protein, Mitochondrial translation factor
01

Overview

Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (GATB), is a mitochondrial protein-coding enzyme that serves as the B subunit of the *glutamyl-tRNA(Gln) amidotransferase* (Glu-AdT, also known as the GatCAB complex) [3][1]. This multimeric complex is essential for the formation of correctly charged glutaminyl-tRNA(Gln) in mitochondria via a transamidation reaction that modifies misacylated glutamyl-tRNA(Gln), thereby ensuring fidelity during mitochondrial protein translation[1][3]. GATB, together with GatA and GatC, catalyzes the conversion of Glu-tRNA(Gln) to Gln-tRNA(Gln) in the presence of glutamine and ATP[3][1][4]. GATB has structural homology with Pet112-like proteins, which are conserved from bacteria to humans and are essential for mitochondrial function[1]. Pathogenic mutations in GATB disrupt mitochondrial translation, causing combined oxidative phosphorylation deficiency and other severe mitochondrial translation disorders[3][4]. GATB is not a direct pharmacological drug target, and no interacting drugs or mechanisms of action are currently reported.

Other names
Glutamyl-tRNA amidotransferase subunit BPET112PET112LHSPC199Glu-AdT subunit BCytochrome c oxidase assembly factor PET112 homologCOXPD41Glutamyl-tRNA(Gln) amidotransferase, subunit BPET112 homologcytochrome oxidase assembly factor PET112 homolog
02

Biological functions

tRNA aminoacylation (formation of Gln-tRNA(Gln) by transamidation)Mitochondrial translationProtein biosynthesis
03

Disease associations

Mitochondrial disease (specifically, Combined Oxidative Phosphorylation Deficiency 41)Other (loss of function mutations are associated with mitochondrial translation disorders)
04

Safety considerations

Essential for mitochondrial translation; loss of function is associated with lethal defects or severe mitochondrial dysfunction in humans[3][4][1].

Beyond the preview

Go deeper on Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (GATB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (GATB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call